Protein Misfolding Disorders: A Trip into the ER

Indexed in: Scopus, EBSCO.

Neurodegenerative disorders such as Amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), Parkinson’s disease (PD), Prion-related disorders (PrD) and Huntington’s disease (HD) share a ...
[view complete introduction]

US $
15

*(Excluding Mailing and Handling)



Role of Alzheimer’s β-Amyloid on Wnt Signaling

Pp. 103-113 (11)

Nibaldo C. Inestrosa, Catalina Grabowski, Macarena Arrazola, Lorena Varela-Nallar and Enrique M. Toledo

Abstract

Recent evidence supports a neuroprotective role for Wnt signaling in neurodegenerative disorders such as Alzheimer´s Disease. In fact, a relationship between amyloid-β-peptide induced neurotoxicity and a decrease in the cytoplasmic levels of β-catenin has been observed. Apparently, Aβ binds to the extracellular cysteine-rich domain of the Frizzled receptor inhibiting Wnt/β-catenin signaling. These studies indicate that a sustained loss of Wnt signaling function may be involved in the Aβ-dependent neurodegeneration observed in Alzheimer’s brain. So far, we have demonstrated that activation of Wnt signaling protects neurons against neurotoxic injuries, including both amyloid-β fibrils and Aβ oligomers by using either lithium, an inhibitor of the glycogen synthase kinase 3β, or different Wnt ligands. In particular, the activation of non-canonical Wnt signaling was able to protect postsynaptic regions and dendritic spines against Aβ oligomers. In conclusion, the activation of the Wnt signaling pathway could be proposed as a therapeutic target for the treatment of AD.

Affiliation:

Centro de Envejecimiento y Regeneracion (CARE), Centro de Regulacion Celular y Patologia “Joaquin V. Luco” (CRCP), MIFAB, Facultad de Ciencias Biologicas, Pontificia Universidad Catolica de Chile, Alameda 340, Santiago, Chile.